Timothy S. Nelson is President at MAP Pharmaceuticals, Inc. (MAPP). They have made 2 open-market trades across 2 companies since 2009, most recently 2024-04-05.
CIK 0001244229
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $129K since 2009, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMPL | BUY | 2021-11-19 | 2021-11-22 | $10.76 | $108K | -11.9% | -2.0% | -28.6% |
| MAPP | SELL · 10b5-1 | 2013-01-23 | 2013-01-25 | $24.76 | $2.0M | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2011-12-20 | 2011-12-22 | $14.51 | $290K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2010-07-01 | 2010-07-02 | $12.15 | $182K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2010-06-01 | 2010-06-03 | $14.41 | $432K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2010-05-13 | 2010-05-14 | $17.09 | $513K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2010-03-01 | 2010-03-03 | $14.47 | $434K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2010-01-11 | 2010-01-13 | $12.17 | $243K | N/A | N/A | N/A |
| MAPP | BUY | 2009-03-05 | 2009-03-09 | $2.17 | $22K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.